The European Commission has partially referred the assessment of the proposed acquisition of certain businesses from UDG Healthcare plc of Ireland by McKesson Corporation to the CMA, at the latter's request. After a preliminary investigation, the Commission has found that the proposed transaction would threaten to significantly affect competition in certain markets in the UK. Those aspects will now be examined by the CMA. At the same time, the Commission has approved the part of the transaction affecting the European Economic Area (EEA) outside the UK. Click here.